💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…
Profile for ImmunoGen, Inc. (IMGN)
« Back to company indexIMGN Chatter Timeline
Stock Ticker for IMGN
Most Active Tweeters for IMGN
| User | Tweets |
|---|---|
| @Tickeron | 7 |
| @TradeWithAlerts | 6 |
| @Traderofstocks1 | 4 |
| @ChartMill | 2 |
| @WALLSTREETODDS_ | 2 |
Recent Tweets for IMGN
 |
@Tickeron $IMGN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/kspO3KNNP6 April 19th 2021, 11:04am |
 |
@hadidy_sara $IMGN, Signals could not be any clearer on the 3-minute chart of IMGN. Awaiting Short Signa https://t.co/Ib3oOtvhGm April 18th 2021, 10:04am |
 |
@TradeWithAlerts Large Print $IMGN Size: 162204 Price: 7.52 Time: 1600 Amount: $1,219,774.08 April 16th 2021, 8:04pm |
 |
@MichalFutera RT @Tickeron: $IMGN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators: https://t.co/imS99zC0J9 #Immuno… April 15th 2021, 11:04pm |
|
@Tickeron $IMGN in Uptrend: RSI indicator exits oversold zone. View odds for this and other indicators:… https://t.co/K1ZVGBLOPM April 15th 2021, 11:04pm |
 |
@Traderofstocks1 $IMGN https://t.co/F2i5vBlzTe April 15th 2021, 10:04pm |
|
@TradeWithAlerts Large Print $IMGN Size: 117876 Price: 7.7 Time: 1713 Amount: $907,645.20 April 15th 2021, 9:04pm |
|
@Tickeron $IMGN's 10-day Moving Average crossed below its 50-day Moving Average on March 30, 2021. View odds for this and oth… https://t.co/2eMHO9R8su April 15th 2021, 1:04am |
|
@Traderofstocks1 $IMGN https://t.co/JdERMI4Wdi April 14th 2021, 1:04pm |
|
@Traderofstocks1 $IMGN https://t.co/TYLOYFCQbo April 13th 2021, 10:04pm |
 |
@A1Syad $IMGN 5-min chart of IMGN, A BUY SIGNAL IS HERE!! https://t.co/6hZ1p3f5t1 April 13th 2021, 6:04pm |
|
@Tickeron $IMGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/BG2eJJGyEs April 13th 2021, 6:04am |
|
@TradeWithAlerts Large Print $IMGN Size: 200162 Price: 7.18 Time: 1600 Amount: $1,437,163.16 April 12th 2021, 8:04pm |
|
@Tickeron $IMGN's in Downtrend: Moving Average Convergence Divergence (MACD) Histogram crosses below signal line. View odds f… https://t.co/LBATwqMzfM April 11th 2021, 11:04am |
 |
@equity_newswire $IMGN ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting https://t.co/XTFqiR6Say April 11th 2021, 5:04am |
 |
@KillerStockCall Expected Biotech News $ADAP SPEARHEAD?1 Initial Data 4-8 June 21 $IMGN FORWARD II Phase 1B Mature Data 4-8 June 21… https://t.co/IdxYZeOWJ0 April 10th 2021, 7:04pm |
|
@KillerStockCall $IMGN "ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting" https://t.co/yqBlsBYEgP… https://t.co/GHJq79rrXN April 10th 2021, 3:04pm |
 |
@MarcJacksonLA $IMGN ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting | Business Wire https://t.co/2lkHFnCgTH April 10th 2021, 2:04pm |
 |
@newsfilterio ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting $IMGN https://t.co/qdMeripKF7 April 10th 2021, 1:04pm |
 |
@StckPro $IMGN NEW ARTICLE : ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting… https://t.co/2VYuUgSqvv April 10th 2021, 12:04pm |
 |
@FlashAlert_me $IMGN [15s. delayed]: Issued Press Release on April 10, 08:30:00: ImmunoGen Presents Preclinical Data on IMGC936 at… https://t.co/odiKkuMILs April 10th 2021, 12:04pm |
 |
@Allstocknews $IMGN ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting From our Stock News Alerts App April 10th 2021, 12:04pm |
 |
@ImmunoGenInc $IMGN Today at #AACR21, we're presenting a preclinical poster highlighting data for our novel ADAM9-targeting ADC,… https://t.co/fDTRmmN9IY April 10th 2021, 12:04pm |
 |
@stock_titan $IMGN ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting https://t.co/Ur0HHrdkYi April 10th 2021, 12:04pm |
 |
@iamtito_ $IMGN - ImmunoGen Presents Preclinical Data on IMGC936 at the AACR Virtual Annual Meeting https://t.co/xY8Bzm6eEv April 10th 2021, 12:04pm |
|
@Tickeron $IMGN's 10-day Moving Average moved below its 50-day Moving Average on March 30, 2021. View odds for this and other… https://t.co/K2fuqmi2Is April 10th 2021, 7:04am |
|
@TradeWithAlerts Large Print $IMGN Size: 108170 Price: 7.56 Time: 1600 Amount: $817,765.20 April 9th 2021, 8:04pm |
 |
@mediasentiment $IMGN new alert at https://t.co/A7qrDarJHY #stocks #daytrading #NYSE #NASDAQ #market 91 April 9th 2021, 10:04am |
 |
@ogatoby @celestocalculus Saw it in a @TechCabal newsletter this morning and I was livid. $IMGN stock wey I manage buy on… https://t.co/IlOYmKv9WG April 9th 2021, 9:04am |
 |
@StuckinStock_ RT @StuckInStock: $IMGN granted ODD for Indolino-benzodiazepine compound (sulfonated DGN549-C) conjugated to the humanized anti-CD123 monoc… April 8th 2021, 9:04pm |
 |
@ChartMill $IMGN was analyzed by 8 analysts. The buy consensus is at 80%. So analysts seem to be mildly confident about $IMGN.… https://t.co/DqtPjgHBQx April 8th 2021, 8:04pm |
|
@ChartMill $IMGN has an excellent technical rating and also presents a decent setup pattern. https://t.co/g9aCzbidZ6 https://t.co/TaBW0QsW0N April 8th 2021, 6:04pm |
 |
@UOAMarkets $IMGN ImmunoGen US Patent & Trademark Office Abstract For Co.'s 'SELECTIVE SULFONATION OF BENZODIAZEPINE DERIVATIVES' April 8th 2021, 2:04pm |
|
@TradeWithAlerts Large Print $IMGN Size: 147145 Price: 7.82 Time: 1730 Amount: $1,150,673.90 April 7th 2021, 9:04pm |
|
@TradeWithAlerts Large Print $IMGN Size: 187875 Price: 7.82 Time: 1600 Amount: $1,469,182.50 April 7th 2021, 8:04pm |
|
@Traderofstocks1 $IMGN https://t.co/9uWhEGMxtJ April 7th 2021, 1:04pm |
 |
@WALLSTREETODDS_ $IMGN Out of the 207 other times IMGN was down 6.9% during a trading day, 59% of the time it traded higher by the… https://t.co/0kRO4sKuFD April 7th 2021, 12:04pm |
|
@Tickeron $IMGN in Uptrend: Stochastic indicator recovers from oversold zone. View odds for this and other indicators:… https://t.co/hTfP080r2w April 7th 2021, 7:04am |
|
@WALLSTREETODDS_ $IMGN Out of the 206 other times IMGN was down 6.9% during a trading day, 57% of the time it traded higher by the… https://t.co/ptOUpgXJ9j April 6th 2021, 9:04pm |
 |
@PMDiChristina Setting up Another leg higher $IMGN https://t.co/EoAg8OOCEp April 6th 2021, 1:04am |
 |
@tradersreport RT @Tickeron: $IMGN's 10-day Moving Average moved below its 50-day Moving Average on March 30, 2021. View odds for this and other indicator… April 5th 2021, 4:04pm |
|
@Tickeron $IMGN's 10-day Moving Average moved below its 50-day Moving Average on March 30, 2021. View odds for this and other… https://t.co/D4OuMErCjG April 5th 2021, 4:04pm |
|
@Tickeron $IMGN's 10-day Moving Average moved below its 50-day Moving Average on March 30, 2021. View odds for this and other… https://t.co/NgEuCGEfK6 April 3rd 2021, 9:04am |
 |
@MrElzoghbyTrade $IMGN insider filling and big buys. The chart helps, the falling wedge needs to be broken out, the Macd and the mom… https://t.co/gx8mSQvfDb April 2nd 2021, 6:04pm |
 |
@InsiderAlerts4U $IMGN: New Insider Filing on ImmunoGen, Inc.'s Director MARK ALAN GOLDBERG: https://t.co/RGEt09Oq5d April 2nd 2021, 6:04pm |
|
@InsiderAlerts4U $IMGN: New Insider Filing on ImmunoGen, Inc.'s Director DEAN J MITCHELL: https://t.co/BYsYffeisq April 2nd 2021, 6:04pm |
 |
@SwingTradeBot Recent $IMGN technical alerts: Stochastic Buy Signal plus 14 more alerts... https://t.co/eJ817HcROq April 2nd 2021, 5:04pm |
|
@newsfilterio 1,666 shares acquired by Mitchell Dean J (Director), reported in a new form 4 filed with the SEC $IMGN https://t.co/3Qp4yU7jh6 April 2nd 2021, 5:04pm |
|
@newsfilterio 1,666 shares acquired by Goldberg Mark Alan (Director), reported in a new form 4 filed with the SEC $IMGN https://t.co/xRUl4MXJhK April 2nd 2021, 5:04pm |
|
@iamtito_ $IMGN - Statement of Changes in Beneficial Ownership (4) https://t.co/2C14z85KHt April 2nd 2021, 5:04pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2021. All rights reserved.
Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Want insights into the biggest revenue-changing events?
Billions of dollars in sales can evaporate overnight as drug patents expire and competitors enter the market.
By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
➤ Free Trial
